JPMorgan Chase & Co’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.3K | Buy |
+15,264
| New | +$46.3K | ﹤0.01% | 5126 |
|
|
2024
Q2 | – | Sell |
-22
| Closed | -$88 | – | 6548 |
|
|
2024
Q1 | $88 | Buy |
22
+6
| +38% | +$24 | ﹤0.01% | 5914 |
|
|
2023
Q4 | $30 | Buy |
16
+5
| +45% | +$9 | ﹤0.01% | 6242 |
|
|
2023
Q3 | $18 | Buy |
+11
| New | +$18 | ﹤0.01% | 6236 |
|
|
2022
Q3 | – | Sell |
-352
| Closed | -$1K | – | 5812 |
|
|
2022
Q2 | $1K | Buy |
+352
| New | +$1K | ﹤0.01% | 5511 |
|
|
2022
Q1 | – | Sell |
-1,103
| Closed | -$7K | – | 5939 |
|
|
2021
Q4 | $7K | Sell |
1,103
-6,937
| -86% | -$44K | ﹤0.01% | 5482 |
|
|
2021
Q3 | $56K | Buy |
8,040
+7,863
| +4,442% | +$54.8K | ﹤0.01% | 4924 |
|
|
2021
Q2 | $2K | Sell |
177
-1,376
| -89% | -$15.5K | ﹤0.01% | 5377 |
|
|
2021
Q1 | $24K | Sell |
1,553
-160
| -9% | -$2.47K | ﹤0.01% | 4924 |
|
|
2020
Q4 | $41K | Buy |
1,713
+198
| +13% | +$4.74K | ﹤0.01% | 4492 |
|
|
2020
Q3 | $26K | Sell |
1,515
-29
| -2% | -$498 | ﹤0.01% | 4444 |
|
|
2020
Q2 | $45K | Buy |
1,544
+1,292
| +513% | +$37.7K | ﹤0.01% | 4241 |
|
|
2020
Q1 | $6K | Buy |
+252
| New | +$6K | ﹤0.01% | 4509 |
|